Edgewise Therapeutics (EWTX) PT Raised to $52 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
Go back to Edgewise Therapeutics (EWTX) PT Raised to $52 at Wedbush
June 1, 2026 8:30 AM EDT
Edgewise to Receive $1.55 Billion in Upfront Cash Consideration and is Eligible to Receive up to $1.1 Billion in Regulatory and Commercial Milestones
Transaction Creates Focused Cardiovascular Company with Enhanced Strategic ClarityÂ
Upfront Proceeds Expected to Fully Fund EDG-7500 Development Through Potential ApprovalÂ
On Track to Report 12-Week CIRRUS-HCM Part D Data in Q2 2026
BOULDER, Colo., June 1, 2026 /PRNewswire/ --Â Edgewise Therapeutics, Inc.... More
June 1, 2026 8:30 AM EDT
Acquisition supports Servier's strategic ambition in rare neurology for patients with high unmet medical needs.Transaction includes sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. Transaction represents total value of up to $2.65 billion.
SURESNES, France, June 1, 2026 /PRNewswire/ -- Servier, an independent international pharmaceutical group governed by a foundation, today announced that it... More
